FADCX
Price
$27.73
Change
+$0.11 (+0.40%)
Updated
Aug 28 closing price
Net Assets
1.52B
RERFX
Price
$62.30
Change
+$0.19 (+0.31%)
Updated
Aug 28 closing price
Net Assets
134.64B
Interact to see
Advertisement

FADCX vs RERFX

Header iconFADCX vs RERFX Comparison
Open Charts FADCX vs RERFXBanner chart's image
Fidelity Advisor Diversified Intl C
Price$27.73
Change+$0.11 (+0.40%)
VolumeN/A
Net Assets1.52B
American Funds EUPAC R5
Price$62.30
Change+$0.19 (+0.31%)
VolumeN/A
Net Assets134.64B
FADCX vs RERFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FADCX vs. RERFX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FADCX is a Buy and RERFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERFX has more cash in the bank: 135B vs. FADCX (1.52B). RERFX pays higher dividends than FADCX: RERFX (0.92) vs FADCX (0.70). FADCX was incepted earlier than RERFX: FADCX (27 years) vs RERFX (23 years). FADCX (1.87) is less costly to investors than RERFX (0.52). RERFX is a more actively managed with annual turnover of: 35.00 vs. FADCX (33.00). FADCX has a lower initial minimum investment than RERFX: FADCX (0) vs RERFX (250). RERFX annual gain was more profitable for investors over the last year : 6.45 vs. FADCX (5.99). FADCX (10.76) and RERFX (10.75) have equivalent 5 years return.
FADCXRERFXFADCX / RERFX
Total Expense Ratio1.870.52360%
Annual Report Gross Expense Ratio1.870.52360%
Fund Existence27 years23 years-
Gain YTD18.43916.101115%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.52B135B1%
Annual Yield % from dividends0.700.9276%
Returns for 1 year5.996.4593%
Returns for 3 years35.5332.15111%
Returns for 5 years10.7610.75100%
Returns for 10 years47.3940.17118%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KLRS3.560.48
+15.58%
Kalaris Therapeutics Inc
NYT59.74-0.09
-0.15%
New York Times Co
NWBI12.63-0.10
-0.79%
Northwest Bancshares
TCI46.09-0.41
-0.88%
Transcontinental Realty Investors
NHPAP18.20-0.16
-0.88%
National Healthcare Properties Inc